FREMONT, Calif.– DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, today announced the launch of InCELL Pulse™ target engagement platform that provides scientists with the ability to generate their own cell-based target engagement assays for confirming compound cell entry and target binding in the native cellular environment.

Monitoring cellular drug penetration and drug-target interaction enables assessment of compound on-target potency and confirmation of mode of action. Current platforms on the market for measuring target engagement focus on a limited set of biochemical or cell-based targets. DiscoverX’s new InCELL Pulse cellular compound-target engagement platform provides drug discovery scientists the ability to create their own target engagement cell-based assays. With InCELL Pulse one can confirm compound cell entry and target binding, validate hits identified in biochemical assays, measure cellular EC50 values, and ran